maraviroc — United Healthcare

Initial criteria

• Patient has CCR5-tropic HIV-1 infection as confirmed by a highly sensitive tropism assay
• AND Patient is currently taking or will be prescribed an optimized background antiretroviral therapy regimen

Approval duration

12 months